Clinical Trials
355 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Tubulis GmbH
JADE
GlaxoSmithKline
MOHSAHRTSS
University of Vermont Medical Center
AHEAD-MERIT
BioNTech SE
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
PIKALO-1
Eli Lilly and Company
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
ILLUMINE
Groupe Oncologie Radiotherapie Tete et Cou
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
LEARN
University of Sydney
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Daiichi Sankyo
FORTIFI-HN01
Bicara Therapeutics
OP-NEU-101
Onchilles Pharma Inc
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Peking University First Hospital
NUTRIMAX
Centre Hospitalier Universitaire, Amiens
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
ORGAVADS
Centre Francois Baclesse
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
University of Chicago
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Canadian Cancer Trials Group
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ALX Oncology Inc.
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Medical University of South Carolina
EGRET
AstraZeneca
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Mayo Clinic
SHERLOCK
University Health Network, Toronto
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Merus B.V.
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Vanderbilt-Ingram Cancer Center
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
EpiBiologics
T-PROSE
Case Comprehensive Cancer Center
Radiotherapy
All India Institute of Medical Sciences
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ModeX Therapeutics, An OPKO Health Company
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
COMPORT
Insel Gruppe AG, University Hospital Bern
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
M.D. Anderson Cancer Center
Eliminate
All India Institute of Medical Sciences
SWOAR
All India Institute of Medical Sciences
Nutritional Status of Head and Neck Cancer Patients
Marmara University
DP-04
AstraZeneca
ATATcH Alternating Treatment Plans for Advanced Cancer
Rutgers, The State University of New Jersey
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Perspective Therapeutics
CHEMOVES
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Biospecimen Procurement for Head and Neck Disorders
National Institutes of Health Clinical Center (CC)
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
University of California, San Francisco
GUIAR
University of Miami
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
National Institutes of Health Clinical Center (CC)
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
University of Virginia
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
LYSARI
Centre Leon Berard
Preventive Physical Activity Intervention in Head and Neck Cancer
Sahlgrenska University Hospital